Art. 37 Directive (EU) 2009/132

In forcecited 1×
1.

Without prejudice to the exemption provided for in Article 143(a) of Directive 2006/112/EC and subject to Article 38 of this Directive, the following shall be exempted:

(a)

therapeutic substances of human origin;

(b)

blood-grouping reagents;

(c)

tissue-typing reagents.

2.

For the purposes of paragraph 1:

(a)

‘therapeutic substances of human origin’ means human blood and its derivatives (whole human blood, dried human plasma, human albumin and fixed solutions of human plasma protein, human immunoglobulin and human fibrinogen);

(b)

‘blood-grouping reagents’ means all reagents, whether of human, animal, plant or other origin used for blood-type grouping and for the detection of blood incompatibilities;

(c)

‘tissue-typing reagents’ means all reagents whether of human, animal, plant or other origin used for the determination of human tissue-types.

  • Opinion of Advocate General Wahl delivered on 2 June 2016. TMD Gesellschaft für transfusionsmedizinische Dienste mbH v Finanzamt Kassel II -Decision

    TMD argues, however, that it can be inferred, by a contrario reasoning, from Articles 37 to 39 of Directive 2009/132 that a distinction should be made between therapeutic plasma and industrial plasma for the purposes of Article 132(1)(d) …

    2 Jun 2016 · 62015CC0412